CONSTELLATION PHARMACEUTICALS INC — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2020)

-$126.4M

Total Assets (FY2020)

$441.9M

Total Equity (FY2020)

$410.7M

Cash Flows from Operating Activities (FY2020)

-$111.4M

Source: CONSTELLATION PHARMACEUTICALS INC 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.